UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15923) 15923
Newsletter (182) 182
Book Chapter (76) 76
Newspaper Article (45) 45
Dissertation (26) 26
Magazine Article (23) 23
Government Document (18) 18
Conference Proceeding (14) 14
Publication (11) 11
Book / eBook (3) 3
Book Review (3) 3
Reference (2) 2
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11492) 11492
science & technology (8960) 8960
life sciences & biomedicine (8613) 8613
female (4889) 4889
biological and medical sciences (4813) 4813
male (4518) 4518
animals (4296) 4296
urokinase (3685) 3685
urokinase-type plasminogen activator - metabolism (3668) 3668
medical sciences (3456) 3456
middle aged (3017) 3017
urokinase-type plasminogen activator - therapeutic use (2745) 2745
adult (2455) 2455
aged (2367) 2367
receptors, urokinase plasminogen activator (1855) 1855
mice (1846) 1846
urokinase-type plasminogen activator - genetics (1813) 1813
urokinase-type plasminogen activator - administration & dosage (1783) 1783
oncology (1656) 1656
fundamental and applied biological sciences. psychology (1554) 1554
biochemistry & molecular biology (1495) 1495
abridged index medicus (1464) 1464
cardiovascular system & cardiology (1333) 1333
thrombolytic therapy (1201) 1201
fibrinolysis (1139) 1139
tumors (1120) 1120
cell biology (1110) 1110
pharmacology. drug treatments (1108) 1108
cells, cultured (1102) 1102
receptors, cell surface - metabolism (1052) 1052
time factors (945) 945
peripheral vascular disease (916) 916
urokinase-type plasminogen activator - pharmacology (887) 887
hematology (885) 885
urokinase-type plasminogen activator (885) 885
cell line, tumor (873) 873
fibrinolytic agents - therapeutic use (841) 841
prognosis (832) 832
tumor cells, cultured (819) 819
urokinase-type plasminogen activator - antagonists & inhibitors (802) 802
kinetics (773) 773
aged, 80 and over (767) 767
treatment outcome (766) 766
rats (753) 753
urokinase-type plasminogen activator - biosynthesis (745) 745
plasminogen - metabolism (741) 741
research (739) 739
cell line (736) 736
neoplasm invasiveness (733) 733
plasminogen activators - metabolism (726) 726
plasminogen activator inhibitor 1 - metabolism (725) 725
urokinase-type plasminogen activator - analysis (700) 700
blood. blood coagulation. reticuloendothelial system (676) 676
molecular sequence data (651) 651
surgery (650) 650
tissue plasminogen activator - metabolism (639) 639
immunohistochemistry (638) 638
molecular and cellular biology (635) 635
streptokinase - therapeutic use (635) 635
gene expression (627) 627
cancer (625) 625
receptors, urokinase plasminogen activator - metabolism (622) 622
thrombosis - drug therapy (611) 611
analysis (592) 592
amino acid sequence (581) 581
research article (580) 580
neurosciences & neurology (576) 576
cardiac & cardiovascular systems (557) 557
myocardial infarction - drug therapy (557) 557
enzyme-linked immunosorbent assay (552) 552
metastasis (548) 548
u-plasminogen activator (548) 548
proteins (542) 542
thrombolysis (542) 542
receptors, cell surface - genetics (541) 541
thrombolytic therapy - methods (541) 541
fibrinolysin - metabolism (531) 531
plasminogen activators - therapeutic use (529) 529
signal transduction (523) 523
rna, messenger - metabolism (516) 516
molecular weight (515) 515
plasminogen activator (515) 515
dose-response relationship, drug (512) 512
adolescent (507) 507
fibrinolysis - drug effects (490) 490
tissue plasminogen activator - therapeutic use (480) 480
plasminogen (478) 478
protein binding (470) 470
urokinase-type plasminogen activator - physiology (464) 464
retrospective studies (462) 462
fibrinolytic agents - administration & dosage (461) 461
health aspects (459) 459
breast cancer (454) 454
upa (452) 452
heparin - therapeutic use (442) 442
follow-up studies (434) 434
transfection (432) 432
cell movement - drug effects (421) 421
binding sites (418) 418
urokinase-type plasminogen activator - blood (417) 417
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14824) 14824
Japanese (675) 675
German (406) 406
Chinese (309) 309
French (230) 230
Russian (183) 183
Italian (109) 109
Spanish (102) 102
Polish (44) 44
Korean (43) 43
Portuguese (11) 11
Czech (9) 9
Hungarian (9) 9
Turkish (8) 8
Dutch (7) 7
Ukrainian (6) 6
Hebrew (5) 5
Danish (4) 4
Romanian (3) 3
Swedish (3) 3
Persian (2) 2
Chamorro (1) 1
Croatian (1) 1
Norwegian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Oncogene, ISSN 0950-9232, 05/2013, Volume 32, Issue 18, pp. 2282 - 2291
Journal Article
The Journal of biological chemistry, ISSN 0021-9258, 04/2010, Volume 285, Issue 14, pp. 10982 - 10992
Journal Article
ACS chemical biology, ISSN 1554-8929, 06/2015, Volume 10, Issue 6, pp. 1521 - 1534
Focal Adhesion Kinase 1 - genetics | Integrin alphaVbeta3 - chemistry | Small Molecule Libraries - pharmacology | Urokinase-Type Plasminogen Activator - antagonists & inhibitors | Humans | Integrins - genetics | Vitronectin - genetics | Integrins - metabolism | Vitronectin - antagonists & inhibitors | Integrin alphaVbeta3 - metabolism | Thermodynamics | Integrin alphaVbeta3 - genetics | HEK293 Cells | Urokinase-Type Plasminogen Activator - chemistry | Binding Sites | Focal Adhesion Kinase 1 - metabolism | Serine Proteinase Inhibitors - pharmacology | Integrin alphaVbeta3 - antagonists & inhibitors | Binding, Competitive | Cell Survival - drug effects | Receptors, Urokinase Plasminogen Activator - chemistry | Serine Proteinase Inhibitors - chemical synthesis | Signal Transduction | Gene Expression Regulation | Small Molecule Libraries - chemical synthesis | Urokinase-Type Plasminogen Activator - genetics | Cell Adhesion - drug effects | Vitronectin - metabolism | Receptors, Urokinase Plasminogen Activator - antagonists & inhibitors | Peptides - pharmacology | Receptors, Urokinase Plasminogen Activator - metabolism | Cell Movement - drug effects | Pyrroles - pharmacology | Pyrroles - chemical synthesis | Urokinase-Type Plasminogen Activator - metabolism | Vitronectin - chemistry | Cell Line, Tumor | Protein Binding | Receptors, Urokinase Plasminogen Activator - genetics | Kinetics | rac1 GTP-Binding Protein - metabolism | Receptor Cross-Talk - drug effects | rac1 GTP-Binding Protein - genetics | Index Medicus
Journal Article
Cancer research (Chicago, Ill.), ISSN 0008-5472, 04/2013, Volume 73, Issue 7, pp. 2070 - 2081
Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Pharmacology. Drug treatments | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Antineoplastic agents | Tumors | Recombinant Proteins - therapeutic use | Surface Plasmon Resonance | Urokinase-Type Plasminogen Activator - antagonists & inhibitors | Receptors, Estrogen - metabolism | Breast Neoplasms - immunology | Humans | Gene Expression Regulation, Neoplastic | Receptor, ErbB-2 - metabolism | Antibodies, Monoclonal - therapeutic use | Immunoenzyme Techniques | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Female | Tumor Cells, Cultured | Real-Time Polymerase Chain Reaction | RNA, Messenger - genetics | Urokinase-Type Plasminogen Activator - genetics | Reverse Transcriptase Polymerase Chain Reaction | Receptors, Urokinase Plasminogen Activator - antagonists & inhibitors | Breast Neoplasms - prevention & control | Receptors, Urokinase Plasminogen Activator - metabolism | Xenograft Model Antitumor Assays | Animals | Image Processing, Computer-Assisted | Urokinase-Type Plasminogen Activator - metabolism | Mice, Nude | Mice | Receptors, Urokinase Plasminogen Activator - genetics | Indium Radioisotopes | Longitudinal Studies | Index Medicus | imaging tumor progression and metastasis | novel anti-tumor agents | new targets | breast cancer | non-invasive imaging
Journal Article
Molecular cancer therapeutics, ISSN 1535-7163, 05/2017, Volume 16, Issue 5, pp. 956 - 965
Life Sciences & Biomedicine | Oncology | Science & Technology | Virulence Factors - genetics | Humans | ErbB Receptors - genetics | Hemangiosarcoma - genetics | Molecular Targeted Therapy | ADP Ribose Transferases - administration & dosage | Exotoxins - administration & dosage | Epidermal Growth Factor - chemistry | Bacterial Toxins - genetics | Urokinase-Type Plasminogen Activator - chemistry | ADP Ribose Transferases - chemistry | Disease Models, Animal | Doxorubicin - administration & dosage | Hemangiosarcoma - pathology | ErbB Receptors - antagonists & inhibitors | Exotoxins - chemistry | Epidermal Growth Factor - genetics | Hemangiosarcoma - drug therapy | Virulence Factors - chemistry | Urokinase-Type Plasminogen Activator - genetics | Bacterial Toxins - chemistry | Receptors, Urokinase Plasminogen Activator - antagonists & inhibitors | ADP Ribose Transferases - genetics | Animals | Dogs | Exotoxins - genetics | Cell Line, Tumor | Bacterial Toxins - administration & dosage | Mice | Receptors, Urokinase Plasminogen Activator - genetics | Neoplasm Staging | Virulence Factors - administration & dosage | Spleen | Drugs | Animal models | Carcinoma | Sarcoma | Epidermal growth factor receptors | Mesenchyme | Toxicity | Minimal residual disease | Doxorubicin | Biological activity | U-Plasminogen activator | Urokinase | Epidermal growth factor | Life span | Data collection | Biocompatibility | In vivo methods and tests | Drug dosages | Index Medicus | targeted toxin | canine | sarcoma | epidermal growth factor receptor | adaptive clinical trial | urokinase plasminogen activator receptor
Journal Article
Strahlentherapie und Onkologie, ISSN 0179-7158, 6/2018, Volume 194, Issue 6, pp. 539 - 551
Journal Article
The Journal of biological chemistry, ISSN 0021-9258, 08/2010, Volume 285, Issue 35, pp. 26878 - 26888
Journal Article